Preferred Label : arbekacin;
MeSH note : structure given in first source;
CISMeF synonym : arbekacine; arbekacin sulfate; habekacin; D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1- 6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-
4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, sulfate; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1- 4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-
6))-N'-((2S)-4-amino-2-hydroxybutyryl)-2-deoxy-L-streptamine;
MeSH synonym : 1-N-((S)-4-amino-2-hydroxybutyryl)dibekacin; 4-amino-2-hydroxybutylyldibekacin;
MeSH CAS label : Butanamide, 4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-((3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy)-4-((2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl)oxy)-3-hydroxycyclohexyl)-2-hydroxy-,
(2S)-;
MeSH Related Number : 51025-85-5 (habekacin); 104931-87-5 (arbekacin sulfate); 51025-85-5 (arbekacin); G7395HZ992;
Registry Number MeSH : 51025-85-5;
Is substance : O;
UNII : G7V6SLI20L;
InChIKey : MKKYBZZTJQGVCD-XTCKQBCOSA-N;
Origin ID : C031986;
UMLS CUI : C4082272;
ATC code(s)
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT